Serina Therapeutics Insider Sells $97,500 in Stock

Randall Moreadith, an insider at the biotech company, has made multiple stock sales since January.

Mar. 21, 2026 at 12:42pm

Got story updates? Submit your updates here. ›

Randall Moreadith, an insider at Serina Therapeutics, Inc. (NYSEAMERICAN:SER), has sold 39,000 shares of the company's stock for a total value of $97,500. This is the latest in a series of stock sales by Moreadith, who has offloaded a total of 57,500 shares since late January 2026.

Why it matters

Insider trading activity can provide insights into a company's performance and the confidence of its leadership. While insider sales do not necessarily indicate negative sentiment, they can sometimes signal that an executive is taking profits or diversifying their holdings.

The details

According to filings with the Securities and Exchange Commission, Moreadith sold the 39,000 shares on March 19, 2026 at an average price of $2.50 per share. Prior to this, Moreadith had sold 6,500 shares on February 2 at $3.03 per share, 6,500 shares on January 28 at $3.57 per share, 2,500 shares on January 22 at $2.95 per share, and 2,000 shares on January 21 at $3.00 per share.

  • On March 19, 2026, Moreadith sold 39,000 shares.
  • On February 2, 2026, Moreadith sold 6,500 shares.
  • On January 28, 2026, Moreadith sold 6,500 shares.
  • On January 22, 2026, Moreadith sold 2,500 shares.
  • On January 21, 2026, Moreadith sold 2,000 shares.

The players

Randall Moreadith

An insider at Serina Therapeutics, Inc. who has made multiple stock sales since late January 2026.

Serina Therapeutics, Inc.

A biotechnology company that develops drugs to treat neurological diseases and pain.

Got photos? Submit your photos here. ›

The takeaway

While insider sales do not necessarily indicate negative sentiment about a company's prospects, they can provide insights into an executive's confidence and plans for their holdings. Investors will likely be watching to see if Moreadith's stock sales continue or if he maintains a larger stake in Serina Therapeutics going forward.